Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease | Zendy

Jagmeet P. Singh | Zendy; Alexander Kulik | Zendy; Raisa Levin | Zendy; Patrick T. Ellinor | Zendy; Jeremy N. Ruskin | Zendy; Jerry Avorn | Zendy; Niteesh K. Choudhry | Zendy

Open Access

Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease

Author(s) -

Jagmeet P. Singh,

Alexander Kulik,

Raisa Levin,

Patrick T. Ellinor,

Jeremy N. Ruskin,

Jerry Avorn,

Niteesh K. Choudhry

Publication year - 2012

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eus074

Subject(s) - medicine , cardiology , atrial fibrillation , coronary artery disease , renin–angiotensin system , angiotensin receptor blockers , incidence (geometry) , angiotensin converting enzyme , blood pressure , physics , optics

Previous studies have suggested that upstream medical therapy to modulate the renin-angiotensin axis may facilitate left atrial remodelling and thereby prevent new-onset atrial fibrillation (AF). The purpose of this study was to evaluate the association between angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blockers (ARB) on new-onset AF in a large cohort of patients with coronary artery disease (CAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research